Skip to main content

Tag: international business

263 Million Cannabis Consumers and Taxation – A Delicate Balance

With 263 million estimated global cannabis consumers and a total addressable market of $344 billion (illicit and legal combined), cannabis is poised to make a material impact on the global economy. As the cannabis markets in Europe, Latin America, Asia and even Africa are beginning to take shape, one commonly overlooked regulatory detail is the effect of taxation on the potential success of these new markets. Specifically, how higher than needed taxes can not only inhibit new market entrants ability to operate effectively, but can also fuel growth within the illicit market.

To that point, while still federally illegal, existing U.S. state cannabis markets provide crucial lessons for emerging legal markets. California, for example, imposed an effective tax rate of nearly 40-50% on retail products causing many consumers to stay loyal to the illicit market. It resulted in a massive dip in projected state tax revenue in their first year of legalization- nearly 90 million dollars short of their goal.

“Tragically, this is not the first time we have seen poorly thought-out imposed taxes have the exact opposite effect than intended;” said Giadha Aguirre de Carcer, Founder and CEO of New Frontier Data, “during our early years observing new U.S. states legalize, consumers in both the states of Oregon and Washington turned to local illicit producers offering more affordable pricing, leading the states to experience growth in their respective cannabis black markets instead of generating additional tax-revenue for the state.”

Anticipating the elasticity -the sensitivity of consumers to prices and price changes -along with other crucial factors such as identification of consumer preferences, is critical when establishing new cannabis markets. Without understanding such delicate market drivers, countries and states alike will fail to meet projected socio-economic goals. Leveraging lessons learned from existing cannabis markets, policy makers can today better plan ahead and avoid such pitfalls to instead maximize growth opportunities of a healthy and balanced legal cannabis domestic market.

“Data and reporting” Beau Whitney, Senior Economist at New Frontier Data says, “are crucial for understanding how to generate maximum revenue, to identify and to eliminate bad actors, and to ultimately better serve consumers and patients so that they do not turn to the black market.” Oregon’s standardization process is one program Whitney believes is currently effectively utilizing data management. For example, Oregon’s model on certifying testing labs and standardizing laboratory testing help elevate minimum quality standards expected by consumers and making it difficult for bad actors to compete.

In short, regions and nations with heavy pockets of cannabis consumers, looking to transition into a legal and regulated market, must better understand consumer preferences, including price sensitivity, so that state imposed taxes work in favor of domestic and regional socio-economic goals, rather than fuel crime and continued illicit trade.

For more insights into the global cannabis industry, follow along with New Frontier Data’s research at www.newfrontierdata.com.

Next up for the International Cannabis Business Conference: Zurich on May 15-16. Discounted, early bird tickets are on sale until April 24th.

European Medical Cannabis Sales Doubled from 2017 to 2018

Unless you are living under a rock, you know that cannabis legalization, for both medical and adult use purposes, is moving forward nation-by-nation across Europe and around the world. European medicinal sales doubled last year, and we can expect growth to continue rather aggressively as progress begets progress. Germany has been the leader on medical cannabis commerce, and the attendance and interest at the recent International Cannabis Business Conference in Berlin demonstrated the optimism industry participants have for the German market. But Germany is certainly not alone, as Italy also showed strong demand, and opportunities abound in burgeoning markets like Switzerland (where the International Cannabis Business Conference is headed on May 15-16), the United Kingdom, Croatia, Spain (where the International Cannabis Business Conference will return to next year!), and several other nations.

Marijuana Business Daily on the release of its extensive report “Medical Cannabis in Europe: The Markets & Opportunities”:

Year-over-year sales doubled in Europe from 2017 to 2018, underpinned by strong demand in Germany and Italy, though the number of MMJ prescriptions decreased in the Netherlands in that time.

Other countries in the European Union took steps in the right direction, either advancing legislation or introducing (or improving) regulations.

Tracking the regulatory progress of these markets is important because it takes years to develop a functional medical cannabis industry – and some markets get snagged over poor, or slow-moving, regulations.

Differing regulations across Europe can make business decisions difficult, especially when trying to do business in North America, and other legal markets as well. Over time, it will be interesting to see whether the EU and other global partners start to harmonize their rules. No matter the current obstacles, the current and future growth of cannabis markets around the world will reward those that stay educated and make the right networking connections.

There is no better place to learn the latest and network with top investors, entrepreneurs, and advocates than the International Cannabis Business Conference. The next International Cannabis Business Conference is in Zurich on May 15-16, a collaboration with CannaTrade. Discounted, early bird tickets are on sale until April 24th